Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

19.70
Delayed Data
As of Aug 26
 -0.07 / -0.35%
Today’s Change
12.25
Today|||52-Week Range
29.50
+8.66%
Year-to-Date
Drugmakers hooked on $10bn opioid habit
Aug 10 / FT.com - Paid Partner Content
 

Today’s Trading

Previous close19.77
Today’s open19.75
Day’s range19.45 - 20.15
Volume879,397
Average volume (3 months)1,310,053
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+72.40%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+1.16+3.10%
ACHNAchillion Pharmaceut...-0.06-0.70%
LCILannett Company Inc-0.60-1.72%
INVAInnoviva Inc+0.17+1.52%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs